Skip to main content
. 2021 May 17;39(20):2247–2256. doi: 10.1200/JCO.21.00280

FIG 3.

FIG 3.

Box plots of (A) 15 days after PT initiation (C1D15), and (B) percent reduction in SULmax in patients with pCR versus no pCR. The horizontal line inside the box shows the median. The lower and upper hinges of the box represent the 25th and 75th percentiles, respectively. The circles represent actual values of D15 and percent reduction in SULmax. pCR, pathologic complete response; PT, pertuzumab and trastuzumab; SULmax, maximum standardized uptake value corrected for lean body mass.